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A working structural model of penicillin-binding 
protein 1B (PBP 1B) from Escherichia coli derived 
from  previous  data  consists of a highly  charged amino- 
terminal cytoplasmic tail, a 23-amino-acid  hydropho- 
bic transmembrane  anchor,  and a 758-amino-acid  per- 
iplasmic  domain.  Using an engineered  thrombin  cleav- 
age  site, we have  investigated  the  solubility  properties 
of the  periplasmic domain of PBP 1B.  Twelve  amino 
acids,  comprised of the consensus  thrombin  cleavage 
site  (LVPRJGS)  and  flanking  glycine  residues,  were 
inserted  into  PBP  1B  just  past  its  putative  transmem- 
brane segment.  To aid  in  purification, a hexahistidine 
tag  was also inserted at  its amino  terminus,  and  the 
engineered  protein (PBP lB-GT/He)  was  purified  and 
characterized. Inclusion of the  thrombin  cleavage  site 
had no effect on the protein’s intrinsic tryptophan 
fluorescence and  affinity  for [ 14C]penicillin G, indicat- 
ing that the protein structure was not significantly 
perturbed. PBP lB-GT/Ha was readily cleaved  by 
thrombin at  low thrombin/protein  ratios  to a protein 
with  properties  consistent  with  the  removal of its cy- 
toplasmic tail and transmembrane regions. Cleavage 
of the  protein  was  dependent upon the presence of the 
thrombin  cleavage  site,  and  the  thrombin-cleaved  pro- 
tein (PBP lBp,,) displayed an identical  affinity  for [‘“C] 
penicillin G binding as wild-type PBP 1B and un- 
cleaved PBP lB-GT/He. [14C]Penicillin G-labeled PBP 
lB,, eluted  from a gel  filtration column in  the  presence 
but not in the absence of 0.7% 3-[(3-cholamidopro- 
pyl)dimethylammonio]-1-propanesulfonic acid,  and 
PBP lB,,, was  found  entirely  in  the  membrane  fraction 
of a thrombin  digest of membranes  containing  over- 
produced PBP lB-GT/HB.  To further  characterize  this 
unusual solubility behavior, purified PBP lB,,, was 
reconstituted  into  lipid  vesicles,  which  were  then 
floated on a sucrose gradient. Floated vesicles con- 
tained >95% of total 1251-penicillin V binding,  indicat- 
ing  that  PBP lB,,, directly  associates  with  lipid mem- 
branes.  These  results  strongly  suggest that  the  peri- 
plasmic  domain of PBP  1B associates  with  membranes 
independent of its  amino  terminal  transmembrane  re- 
gion. 
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Penicillin-binding  proteins  (PBPs)’  are  membrane-bound 
enzymes that catalyze the  final  stages of peptidoglycan syn- 
thesis in bacterial cells (1, 2). Penicillin,  due to  its  structural 
similarity  to  the D-alanyl-D-alanine  carboxyl terminus of the 
peptide moiety of peptidoglycan, exerts its lethal effect by 
binding  to  and covalently reacting  with  PBPs,  thus  preventing 
the  cross-linking of the  peptide  chains of the peptidoglycan. 
In Escherichia coli there  are  at  least seven PBPs, which can 
be divided into two groups  based  upon  genetic and biochemical 
analysis. The high molecular weight PBPs,  PBPs  lA,  lB, 2 
and 3, are involved in diverse  cellular  processes such  as cell 
elongation, cell shape, and cell division, whereas the low 
molecular  weight PBPs,  PBPs 4, 5 and 6, are  not by them- 
selves essential for cell growth, since each can be deleted 
without apparent deleterious  effects (reviewed in Ref. 1). 
Recent evidence, however, suggests that  the  activity of either 
PBP 5 or 6 is involved in cell growth by regulating the 
availability of peptidoglycan precursors, especially when the 
activity of PBP 3 is limiting (3). All of the  PBPs  contain a 
serine residue in the active site of the penicillin-binding 
portion of the  protein  that  forms a  covalent  bond  with peni- 
cillin (4-7). The roles of other specific amino acids in the 
catalytic cleft of the  penicillin-binding region of PBPs  has 
been the focus of several recent  reports (8, 9). 
Several  studies  have focused on  the  function of PBP 1B. 
PBPs 1A and  1B  are  thought  to be involved in cell elongation; 
mutants lacking either  PBP 1A or lB,  but  not  both,  are viable 
(10, 11), and  therefore each of these  PBPs is able to compen- 
sate for the absence of the  other.  Mutants lacking PBP 1B 
have  only about  10% of the peptidoglycan synthesis  activity 
of wild-type cells, however, and  thus  PBP  1B is thought  to be 
the major  peptidoglycan synthetase in E. coli (12,13). Deletion 
of PBP  1B also results in a decreased growth rate and an 
increased sensitivity to lysis by the inactivation of PBP 2, 
either by specific antibiotics or by mutations that alter its 
stability (10, 14).  The peptidoglycan  synthesized by PBP 1A 
alone is therefore likely to be partially defective, even though 
it  is sufficient to  support growth. Purified PBP  1B  has been 
shown to catalyze both a penicillin-sensitive transpeptidase 
activity  and a penicillin-insensitive transglycosylase activity 
(15, 16). Several experiments with PBP 1B have localized 
these two activities  in  the  primary  structure of the  protein. 
Cleavage of PBP  1B with low amounts of trypsin  results  in 
the  formation of a 50-kDa fragment that retains penicillin 
binding (16, 17), which suggests that  the penicillin-binding 
PBP 1B-H6, PBP 1B containing a hexahistidine tag; PBP IB-GT/ 
The abbreviations used are: PBPs, penicillin-binding proteins; 
&, PBP 1B containing an inserted thrombin-cleavage site and a 
hexahistidine tag; PBP IBper, periplasmic domain of PBP 1B (residues 
90-844); PAGE, polyacrylamide gel electrophoresis; IPTG, isopro- 
pyl-1-thio-P-D-galactopyranoside; CHAPS, 3-[(3-~holamidopropyl) 
dimethylammonio]-1-propanesulfonic acid NTA, nitrolotriacetic- 
acid. 
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portion of the protein  exists  as  a proteolytic domain. Since 
the active site  serine residue of PBP 1B is at residue 510 (5), 
and the same residue in the related lower molecular weight 
PBPs (which are monofunctional) is only 40-50 amino acids 
in from the amino terminus, it follows that  the penicillin- 
binding domain (and by inference the transpeptidase  domain) 
is located in the carboxyl-terminal half of the PBP 1B se- 
quence. The best evidence for the location of the transglyco- 
sylase domain comes from the measurement of transglycosy- 
lase activity in membranes from cells producing truncated 
forms of PBP  lB, in which various portions of the carboxyl 
terminus of PBP 1B were  removed  by deleting the correspond- 
ing DNA in an expression plasmid. These  studies indicated 
that deletion of residues 423-844 or 478-844 resulted in the 
retention of significant transglycosylase activity in the mem- 
brane fraction, but the new peptidoglycan synthesized by 
these membranes was not cross-linked (16). Thus,  a working 
model emerges for PBP 1B in which the amino-terminal 
portion of the protein is the transglycosylase domain that 
polymerizes the glycan chains, and the carboxyl-terminal 
portion is the transpeptidase domain that catalyzes the cross- 
linking of the peptide chains. 
On SDS-polyacrylamide gels, PBP 1B consists of at least 
three bands of varying intensity,  termed a,  @, and y. Genetic 
and biochemical analysis has determined that  the a and y 
components represent two distinct translation start sites 
within the p o d  gene that encodes PBP 1B and that @ is 
derived from CY by proteolysis (18, 19). Each of the three 
components has been isolated from SDS-polyacrylamide gels, 
renatured, and shown to possess both transpeptidase and 
transglycosylase activities (20). Complementation studies in 
a PBP lAta PBP 1B- strain have also shown that the y 
component alone is sufficient to rescue growth at  the restric- 
tive temperatures.  These same studies have also shown that 
the last 64 amino acids at the carboxyl-terminal do not 
contribute to  its function, as deletion of these amino acids 
still results in a functional protein as assayed by penicillin 
binding and complementation (18). 
The topology of PBP 1B has also been investigated in some 
detail. Analysis of the hydropathy plot of PBP 1B predicts a 
single stretch of 25 hydrophobic amino acids at residues 64- 
87, indicating that  this region  may function as  a  both  a signal 
sequence and transmembrane anchor. In an elegant set of 
experiments, the coding region for the mature form of TEM 
@-lactamase was fused in frame to random positions along the 
entire coding region of PBP lB, and the ability of these 
fusions to confer resistance to ampicillin was investigated 
(21). All p-lactamase fusions from residues 88 to 844 of PBP 
1B resulted in high  level resistance to ampicillin, which indi- 
cated that this region was periplasmic. These experiments 
reinforced the topology of PBP 1B suggested by its hydropa- 
thy plot and led to the model in which residues 1-63 are 
intracellular, 64-87 are  transmembrane,  and 88-844 are  per- 
iplasmic. These  results fit the generally accepted model that 
PBPs are essentially periplasmic enzymes that are anchored 
in the cytoplasmic membrane by a single transmembrane 
segment (22-25). This model therefore predicts that residues 
88-844 would make a  candidate for obtaining  a soluble form 
suitable for crystallization studies of PBP 1B. However, in 
this study we report that a truncated protein comprising 
residues 90-844 is not soluble in the absence of detergents 
and  interacts with membrane vesicles in a  manner  indistin- 
guishable from native protein. We conclude from these exper- 
iments that PBP 1B interacts with the membrane at a region 
distinct from its  transmembrane anchor region, although the 
nature of this  interaction is as yet unknown. 
EXPERIMENTAL  PROCEDURES 
Materials-All restriction and modifying enzymes were  from Phar- 
macia LKB Biotechnology Inc. [3H]Penicillin G was a gift of Dr. Pat 
Cassidy of Merck, Sharpe, and Dohme.  '251-Penicillin V was formed 
from p-(trimethylstanny1)phenoxyacetamindopenicillin (a gift of Dr. 
Larry Blaszczak, Eli Lilly and Co.) as described by Blaszczak et al. 
(26). Synthetic oligonucleotides were synthesized on a Milligen/ 
Biosearch DNA synthesizer. The  strains of E. coli used were JM103 
with M13 vectors, CJ236 (dut ung) for the production of uracil- 
containing M13 phage, and NK5830 (F' lacP prolarg Ahc proxllr 
NalA rif recA-56 suo ara thy) for the overexpression of PBP 1B 
constructs.  Luria-Bertani  broth (LB) was used for bacterial growth 
and was supplemented with 50 pg/ml of kanamycin or 34 pg/ml of 
chloramphenicol when appropriate. Sequencing was performed with 
the Sequenase I1 kit from United States Biochemical. 
Construction of PBP 1B Containing a Thrombin Cleavage Site and 
an Amino-terminal Hexahistidine Tag-The  gene  for PBP 1B-7 
(hereafter referred to only as PBP lB), which was modified by 
mutagenesis to contain 34 bases 5' of the second translation start 
site of the ponB gene (27), was cloned into pTTQ18K (28) as an 
EcoRI-BamHI fragment to yield pRN1B-E. The EcoRI-SaZI fragment 
of pRN1B-E, which encodes the amino-terminal half of PBP 1B, was 
subcloned into M13mp19 and used to make uracil-containing single- 
stranded DNA temdate in CJ236 as described bv Kunkel et al. (29). 
The following oligonucleotide, 5"GGCGTTTATCTCGATCA- 
ATTCGTAGCCGT-3'. was used to loop-in the codons for 12  extra 
AGGTGGTCTGGTTCCGCGTGGATCCGGTGGTGGTGGTAAA- 
amino acids (underscored; also see Fig: 1). Addition of these extra 
amino acids results in the formation of a thrombin cleavage site 
(LVPRGS) flanked by glycine residues just past the putative mem- 
brane-spanning region of PBP 1B (see  Fig. 1A). Mutants  containing 
a  BamHI  site (from the loop-in oligonucleotide) were identified and 
sequenced to ensure that correct insertion had occurred. 
Mutant phage containing the thrombin cleavage site were then 
used to make uracil-containing single-stranded DNA terndate. and 
the following oligonucleotide, 5'-CCGATGCCGCGCAAACACCAT- 
CACCATCACCATGGTAAGGGCAAAGGC-3' was used to loop-in 
the codons for 6 histidine residues (underscored) along with a  silent 
NcoI site. This same oligonucleotide was also used io loop-in the 
hexahistidine tag  into the coding sequence of PBP 1B. The 6 histidine 
residues were located after the fourth amino acid of either wild-type 
PBP 1B or PBP 1B containing the thrombin cleavage site and 
provided a means to rapidly purify these proteins on immobilized 
Ni2+-chelated NTA resin (30). Positive phage were identified by the 
presence of the NcoI site  and sequenced; to generate the expression 
plasmid for the modified PBP,  the EcoRI-Sac11 fragment from one 
of the positive phage was used to replace the corresponding fragment 
in  pRN1B-E, yielding either pRNlB-Hs or pRNIB-GT/H, (Fig. IB). 
Expression and Purification of PBP lB-GT/H6-Cu~tures  (6  liters) 
of NK5830/pRN1B-GT/H6 were  grown to  an ODGoo f 0.5, and IPTG 
was added to 300 p M  to induce transcription from the tac promoter. 
After inducing for 2 h,  the cells were harvested by centrifugation and 
the cell paste was frozen at -20 "C overnight. The next morning, the 
cells were resuspended in 40 ml of 50 mM sodium phosphate buffer, 
pH 7.0, 1 mM phenylmethylsulfonyl fluoride (lysis buffer), and lysed 
by three passes in a French pressure cell at 13,000 pounds/square 
inch. The cell lysate was then centrifuged at 100,000 X g for 1 h  and 
the  supernatant discarded. The membrane pellet was resuspended in 
lysis buffer, and the protein concentration was determined by the 
Lowry method (31). The membranes were diluted to 10 mg/ml with 
phosphate buffer, mixed with an equal volume of 2% CHAPS, 2 M 
NaCI, 50 mM Tris. HCI, pH 7.5, and incubated at room temperature 
for 1 h to extract the 1B proteins. Following extraction, the mixture 
was centrifuged at 120,000 X g for 1.5  h. The  supernatant was  mixed 
with an equal volume of 66% ammonium sulfate, incubated on ice  for 
1.5 h or overnight at 4 "C, and  the precipitated PBP  lB-H6 or PBP 
lB-GT/Hs was collected by centrifugation at 15,000 X g for 15 min. 
The precipitates were redissolved in 0.7% CHAPS, 0.5 M NaCI, 25 
mM Tris.HC1, pH 8.0 (buffer A), and applied to an NTA column (3- 
ml bed volume) equilibrated in the same buffer. The columns were 
washed with 10 volumes of buffer A containing 1 M NaC1, followed 
by 10 volumes of buffer A containing 10 mM imidazole. PBP 1B-H6 
or PBP 1B-GT/H6 were eluted with buffer A containing 120 mM 
imidazole. In some experiments, the CHAPS detergent was exchanged 
for 8-octylglucoside by washing the bound PBP 1B-GT/H6 with 10 
volumes of  0.7% 8-octylglucoside, 0.5 M NaC1, 25 mM Tris.HC1, pH 
8.0, 10 mM imidazole, and  then eluting with the same buffer contain- 
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ing 120 mM imidazole. Fractions containing PBP 1B-H6 or PBP 1B- 
GT/& were identified by absorbance at 280 nm, pooled, and the 
imidazole  was  removed either by dialysis or by dilution/ultrafiltration. 
Fluorimetric Analysis of Purified PBP IB-H6 and PBP IB-GT/ 
&"The concentrations of the purified  proteins were determined by 
the method of Lowry and by  ODaso. The proteins were then diluted 
into either buffer A or 6 M guanidine. HCI,  25 mM Tris. HCI, pH 7.5, 
to make a 0.25 p M  solution and their emission spectra analyzed  on a 
Perkin-Elmer model  MPF-2A Fluorimeter. The proteins were  excited 
at 290 nm,  and the emission spectra were  recorded  with a 12-nm slit 
width. 
Thrombin Cleavage of PBP IB-GT/He and Purification of PBP 
IB,,-Purified PBP 1B-GT/Hs in  buffer A was incubated at various 
thrombin/protein ratios for 1 h at 37 "C. Following incubation, the 
proteolyzed  samples  were  subjected to SDS-polyacrylamide  gel  elec- 
trophoresis on an 8% gel.  For  large  scale purification, PBP lB-GT/ 
HB (0.4 mg/ml) was digested with thrombin at a ratio of 1:250 
(thrombin/protein) for 1 h at 37 "C, and then reapplied to  a Ni2+- 
NTA column as described above. The eluant from the Ni2+-NTA 
column, which contained thrombin-cleaved PBP 1B-GT/H6 (PBP 
1BpJ  purified away  from any  undigested protein, was then used  for 
subsequent  experiments. 
Gel Filtration of PBP lB,, in  the  Presence and Absence of Deter- 
gents-Purified PBP lB,, in buffer A was incubated with ["C] 
penicillin G (40  pg/ml)  for 10 min at 30  "C. The labeled  protein  was 
then layered onto a Sephacryl HR-200 column (1 X 50 cm) equili- 
brated  in 25 mM Tris.HC1,  pH  8.0, 500 mM NaCl, k 0.7%  CHAPS, 
and eluted  in the same  buffer. Fractions (0.4  ml)  were  collected, and 
140-pl  aliquots  were  analyzed  by  liquid scintillation counting  in 5 ml 
of ScintiVerse BD (Fisher). The column  was standardized by running 
the following  compounds under  both  elution  conditions: blue dextran 
(void  volume),  bovine  serum  albumin  (68 kDa), and 3H20 (included 
volume). 
Reconstitution of PBP  IB Proteins-Reconstitution of PBP 1B 
proteins into lipid vesicles and flotation on sucrose gradients was 
done  essentially as described  by  Waxman and Strominger  (32). An 
aliquot (3 mg/experiment) of asolectin  lipid,  purified  as  described by
Kagawa and Racker  (33) and stored at -20  "C in CHC13/MeOH  (2:1, 
v/v), was dried under a stream of argon in a 15-ml polypropylene 
tube.  The  residue was  twice  redissolved in  diethyl ether and reevapo- 
rated under argon. The lipid was redissolved and then sonicated 
(three 20-s bursts) in 0.2  mi  of  4.4%  8-octylglucoside, 100 mM Tris. 
HC1, pH  8.0,  followed  by the addition of  60  pg of protein  in 0.5 ml of 
0.7%  0-octylglucoside,  25 mM Tris.HC1,  pH 8.0, 500 mM NaCl. The 
clear  solution  was then dialyzed at 4 "C versus three changes of 500 
ml of 25 mM Tris. HCI, pH 7.5, 30 mM sucrose, 0.5 M NaCl.  Sucrose 
was omitted from the final  dialysis  buffer. 
Flotation of Lipid Vesicles on a Sucrose Gradient-The slightly 
opaque  samples of reconstituted  lipid  vesicles  were  spun at 750 X g 
for  10  min to remove  insoluble material, and 0.25 g of sucrose  was 
dissolved in 0.38 ml of the vesicle preparations. The samples were 
placed  in a 5-ml  centrifuge  tube,  layered  with a linear gradient of 42 
to 12% sucrose,  and  spun  for 16 h at 37,000  rpm  in a,SW 50.1 rotor 
(Beckman Instruments). Under  these  conditions, the vesicles floated 
to the top of the sucrose  gradient. Fractions of 0.3  ml  were  collected, 
and the location of the lipid  vesicles  was  ascertained by dilution of 
50 pl into 450 pl of 25 mM Tris.HCI, pH 7.5, 0.5 M NaCl and 
determining the light scatter at 350 nm. The location of PBP proteins 
was determined by incubating 20 pl of  each fraction  with 30 pg/ml  of 
['261]penicillin V for 10 min at 30 "C followed by SDS-PAGE and 
silver staining to locate the protein  bands.  After  drying the gel, the 
protein bands were cut out and counted in a gamma counter. In 
intermediate fractions where there was  no  visible  silver staining, the 
area  corresponding to the position of the protein was also removed 
and  counted. 
SDS-Polyacrylamide  Gel  Electrophoresis-Samples prepared as de- 
scribed above were submitted to  electrophoresis on an 8% SDS- 
polyacrylamide gel (34). For samples incubated with either [3H] or 
['4C]penicillin G, the gel was treated with EN3HANCE (Du Pont- 
New England Nuclear), dried, and exposed to Fuji RX film. For 
location of protein bands, the gel was stained with either silver or 
Coomassie Brilliant Blue  R-250.  For the estimation of band intensity 
on x-ray film, fluorographs were submitted to densitometry on a 
Hoeffer HS300 scanning densitometer hooked to an Apple11 com- 
puter. 
RESULTS 
Properties of a PBP 5-PBP 1B Fusion  Protein-The  ap- 
parently  straightforward topology of PBP 1B as  predicted by 
a hydropathy  plot  and  8-lactamase fusion experiments  sug- 
gests that  a soluble form could be constructed in which 
residues 1-87 were replaced by an exogenous signal sequence. 
This  in  fact  was  reported by Spratt  and co-workers  (35), in 
which the  signal  sequence  and  first  10  amino  acids of mature 
PBP 5 were fused in  frame  with residues 88-844  of PBP 1B. 
Expression of this  construct  resulted  in  the  appearance of a 
new PBP of the  expected size, but  the PBP was recovered 
only  partly  in  the soluble fraction,  and  the biochemical char- 
acterization of the PBP was not pursued. Our laboratory  also 
constructed a similar  fusion  protein,  except  that  the  signal 
sequence of PBP 5 was fused  directly  with residues 93-844. 
In our hands, the PBP 5-1B fusion protein was recovered 
mostly in the membrane fraction (>85% as determined by 
immunoblotting),  with  the  remainder  appearing  in  the  super- 
natant (data not shown). When  the two fractions were ana- 
lyzed by [14C]penicillin G binding, however, the  supernatant 
fraction  appeared to be  largely inactive. Because the  majority 
of ['4C]penicillin G binding was present in membranes, we 
extracted  the  fusion  protein  from  membranes  with  CHAPS 
detergent  and  purified  it  in  reasonable  quantities.  When  this 
protein was submitted to gel filtration  in  the  presence 0.7% 
CHAPS,  it  eluted at a position expected of a protein it's size. 
When  the  detergent was  removed,  however, no  protein  eluted 
from  the  column, suggesting that residues 93-844 were insol- 
uble in  the  absence of detergent  (data  not  shown).  An  alter- 
native  explanation of this  result was that  the  signal  sequence 
from PBP 5 was not cleaved during  transport and mediated 
the insolubility of the protein due to its hydrophobic core. 
This  latter possibility  was tested  by  sequencing  the  purified 
protein.  Unfortunately,  no  sequence could be obtained,  and 
thus we were still  not  able  to unequivocally distinguish be- 
tween  the  two  scenarios. 
Construction of pRN1B-GT/H6-Because of some of the 
difficulties of growing the strain and purifying the protein 
from  it,  the  unexpected  results of the  solubility of the  fusion 
protein,  and  the possibility that  the signal  sequence was still 
attached, we decided to  try a different  approach  for  investi- 
gating the behavior of the  periplasmic  portion of PBP 1B. In 
developing this  study, we reasoned  that inclusion of several 
amino  acids  just  on  the  carboxyl-terminal side of the  putative 
membrane-spanning region of PBP 1B might be tolerated 
and  still allow the  protein  to fold correctly. We  therefore used 
mutagenesis to insert  the  codons  for a thrombin cleavage site 
(Leu-Val Pro-Arg-Gly-Ser) into PBP 1B (PBP 1B-GT, Fig. 
lA). Thrombin was chosen  as a protease  due  to  its  availability 
and high  specificity.  Because of the possibility that  thrombin 
would not be able to recognize this  site so close to the folded 
structure of the periplasmic portion of PBP lB, we also 
introduced 2 glycine  residues at the  amino  end  and 4 glycine 
residues at   the  carboxyl end of the cleavage site. Previous 
results  by  Guan  and  Dixon (36) have  shown  that inclusion of 
glycine residues  past  the  thrombin cleavage site of glutathi- 
one-S-transferase fusion proteins resulted in a much more 
efficient cleavage of the  recombinant  protein. 
We  also  desired  an easy method  for  purifying our PBP 1B 
proteins without using ampicillin affinity chromatography. 
The  harsh  conditions  for  elution (1 M NHzOH, pH 8.7, for 3 
h)  from  the  ampicillin  resin  and  reports  that  PBP  1B purified 
in  this  manner  exhibited very low stoichiometry of penicillin 
binding (16) made this purification procedure unattractive. 
Recently,  the  addition of a hexahistidine "tag" onto  the  amino 
or carboxyl terminus of the  protein  and  purification of the 
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FIG. 1. The NHz-terminal architecture of PBP lB-GT/He and expression vector for the overproduction of PBP 1B proteins. 
A ,  the  primary  sequence of the  amino  terminus of PBP  1B-GT/H6 (a derivative of PBP  1B-7) is shown  along  with  both  the  hexahistidine 
and  thrombin cleavage site  insertions. The unusually  high  percentage of positively charged  amino  acids  in  the cytoplasmic tail  is highlighted, 
and  the sequence is  delineated  into  putative cytoplasmic tail  and  membrane-spanning regions. The arrow designates  the  bond cleaved by 
thrombin. B,  the  expression vector used to  overexpress PBP  lB-GT/H,  is a pTTQ18 derivative (28) containing  the tac promoter  and l a d q  
gene. The normal ampicillin resistance gene  was  replaced with  the gene conferring  kanamycin resistance. 
tagged protein  on  an immobilized Ni2+-chelante  resin  (NTA) 
has been pioneered by Hochuli and colleagues (30). This 
method has several advantages: 1) it is a mild chromato- 
graphic  procedure, 2) chromatography  can  be  carried  out  in 
0.5 M NaCl  (purified PBP  1B precipitates  in low salt  buffers), 
and  3)  it allows the  purification of the tagged protein  in a 
single chromatographic  step.  We  therefore  introduced codons 
for 6 histidine residues in between the  fourth  and  fifth  amino 
acid codons of the gene encoding both  PBP  1B  and  PBP  1B- 
GT (Fig. 1A).  The  reconstructed expression plasmid  contain- 
ing the gene for PBP  1B with both the hexahistidine and 
thrombin cleavage site  insertions ( pRNlB-GT/H6)  is shown 
in Fig. 1B. 
Expression and  Purification of PBP 1 B-GT/Hs-NK5830 
cells harboring  pRNlB-GT/HG were grown to  an ODso0 of 0.5, 
and  the tac promoter was induced  with 300 PM IPTG for 2 h. 
Fig. 2, lunes 2 and 3, shows an  immunoblot of the  expression 
of the protein before and after the addition of IPTG. To 
determine  whether  the expressed protein would bind  radiola- 
beled antibiotic, the cell lysates were incubated with [‘‘C] 
penicillin G,  submitted  to  electrophoresis,  and  prepared for 
fluorography  (Fig. 2, lanes 4 and 5). These  results  indicated 
that  the expressed protein was  produced in high amounts  and 
was  capable of binding [14C]penicillin G. 
Purification of PBP 1B-GT/H6 (and PBP lB-H6) was 
accomplished as follows: membranes  from  IPTG-treated cells 
were extracted  with 1% CHAPS  and 1 M NaC1. This  extrac- 
tion  resulted  in  the solubilization of 50-70% of PBP  lB-GT/ 
H6, which was then  precipitated from the  detergent solution 
in 33% ammonium sulfate. The ammonium sulfate precipi- 
tation itself results in a significant purification step and 
allowed the protein to be dissolved in a small volume for 
purification on a Ni2’-NTA column. The precipitate was 
redissolved in 25 mM Tris.HC1, pH 8.0, 0.5 M NaC1, 0.7% 
CHAPS  and applied to a Ni2+-NTA  column,  and  after  exten- 
sive washing to remove unbound proteins, PBP  1B-GT/H6 
was eluted with the above buffer containing 120 mM imidaz- 
ole. PBP lB-GT/HG at this  stage was essentially  a  single band 
on a Coomassie-stained SDS-polyacrylamide gel (Fig. 3A, lane 
6). A gel indicating  the  purity of PBP  1B-GT/H6  at various 
stages of the  purification is shown in Fig.  3A. 
The samples from steps along the purification were also 
assayed by [’Hlpenicillin G binding and fluorography (Fig. 
3B, lanes 8-13). Interestingly, the intensity of the labeled 
PBP  1B-GT/H6  band greatly  increased  upon extraction from 
the  membrane  with 1% CHAPS, 1 M NaC1, which indicated 
that  the expressed protein  in  membranes was not  binding a 
stoichiometric  amount of labeled antibiotic.  This  latency of 
antibiotic  binding  has also been observed for overexpressed 
PBP  1B  and is not a result of the  extra  amino acids inserted 
into  PBP  1B-GT/H6.  We believe this behavior may be due to 
the  sequestering of the overexpressed protein at membrane 
adhesion  sites, which prevents  the access of [‘Hlpenicillin G 
to  the  binding  sites of PBP  lB-GT/Hs (see “Discussion”). 
Biochemical Analysis of P B P  lB-GT/HG-Because of the 
possibility that  the  addition of the  extra  amino acids in  PBP 
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1B-GT/H6  might alter  the  structure of the protein by causing 
it  to fold incorrectly, we sought to quantitatively assess the 
integrity of the protein. To address the penicillin binding 
activities of the purified proteins, the affinities of PBP 1B- 
Hs and  PBP 1B-GT/H6 for ['4C]penicillin G were determined 
as described under "Experimental Procedures.'' Because of 
the covalent nature of the interaction, the affinity of a PBP 
for radioactive antibiotic is defined as  the concentration of 
that antibiotic that results in  the covalent labeling of 50% of 
the  PBP under defined conditions (in this case, 10 min at  
30  "C; see Ref.  37 for further details). The  saturation curves 
are shown in Fig. 4. From these data,  it was determined that 
both  proteins had  an identical  affinity for ['4C]penicillin G 
(-2.3 pg/ml or 6.2 nmol/ml). These values are very similar to 
the value reported for PBP  1B in E. coli membranes (3.0  pg/ 
ml; (38)). 
We also sought to compare the overall structure of PBP 
lB-He with PBP lB-GT/Hs by using intrinsic tryptophan 
fluorescence. Both of these proteins have 13  tryptophan res- 
idues; 2 are in the  transmembrane anchor,  3 are in the amino- 
terminal half, and 8 are in the carboxyl-terminal half of the 
protein. Equimolar solutions (0.25 p ~ )  of PBP  lB-Hs  and 
PBP  1B-GT/H6 in 25 mM Tris. HC1, pH 8.0,  500 mM NaCl, 
0.7% CHAPS were excited at  290 nm, and a scan of their 
respective emission spectra is shown in Fig. 5.  Also shown in 
Fig. 5 are  the emission spectra of the two proteins in 6 M 
guanidine. HCI, 25 mM Tris. HCl, pH 8.0. It is clear from 
these data  that  the intrinsic fluorescence of PBP  lB-GT/He 
under  native  conditions is superimposable with PBP  lB-Hs 
(X,,, = 334 nm). Upon denaturation,  the emission peak de- 
creased by 50% and was shifted 10 nm  to higher wavelength. 
Since the spectra for the two proteins are superimposable, it 
is very likely that  the two proteins have nearly identical three- 
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FIG. 2. Expression of PBP lB-GT/Hs in NK5830 cells. 
NK5830 cells harboring pRNlB-GT/HG were  grown to 0.5 ODm  and 
then induced for 2 h with 0.3 mM IPTG. Cells from 1 ml of culture 
were pelleted, resuspended in 100  pl of phosphate buffer, and 
subjected to two cycles of freeze/thaw. The mixture was then treated 
with RNase A and DNase I  until the solution was no longer viscous. 
A, aliquots (10 p l )  of treated cells were separated on a 10% SDS- 
polyacrylamide gel and transferred to nitrocellulose, and  the bands 
were  visualized  by immunoblotting with antisera  against PBP 1B. B, 
aliquots (10 pl) of treated cells were prebound with ['4C]penicillin G 
at  a final concentration of 40 pg/ml for 10 min at  30 "C before 
subjecting to electrophoresis as described above. The bands were 
visualized by fluorography. Lanes 1 and 4, membranes (10 pg) from 
PBP 1B overexpressing cells; lanes 2 and 5, uninduced NK5830 
(pRNlB-GT/H6) cells; lunes 3 and 6, NK5830 (pRN1B-GT/H6) cells 
induced with 0.3 mM IPTG. 
dimensional structures, and therefore the additional amino 
acids in PBP  lB-GT/Hs have not altered the folding of the 
protein. 
Cleavage of PBP lB-GT/He with Thrombin and Purification 
of the Cleaved Protein-To determine whether thrombin 
would cleave PBP lB-GT/He and to assess its specificity, 
thrombin digests of both PBP  lB-Hs  and PBP lB-GT/Hs 
were submitted to electrophoresis on an 8% SDS-polyacryl- 
amide gel, which easily separated undigested protein from 
cleaved product. The purified PBP 1B proteins were in- 
cubated with thrombin at  either a 1:lOO or a 1:500 ratio 
(thrombin/protein, w/w) for 30 and 60 min at  37 "C (Fig. 6). 
Digestion of PBP lB-GT/Hs by thrombin resulted in the 
appearance of a new band  consistent with the removal of the 
cytoplasmic tail  and membrane anchor of the protein and  the 
loss of 6400  Da. Thrombin cleaved the  PBP  lB-GT/Hs to  a 
significant extent even at  a weight ratio of 1:500, and the 
digestion was essentially complete in 30 min at  a 1 : lOO ratio. 
Digestion of PBP  lB-H6 by thrombin at  the same ratios as 
above had no effect on the mobility of the protein (Fig. 6, 
lanes 4-7), indicating that  the digestion was dependent upon 
the presence of the engineered thrombin cleavage site. In 
other experiments, it was determined that  at identical ratios 
of thrombin  to  PBP 1B-GT/H6 the  extent of digestion was 
increased when the concentrations of the two proteins were 
increased. 
One of the goals of this project was to ensure that  the 
cleaved cytoplasmic tail/membrane  anchor region of the pro- 
tein was not still non-covalently attached  to  the remainder of 
the protein; if the periplasmic region of the protein remained 
insoluble in the absence of detergents, it would  be important 
to show that it was not due to  the continued non-covalent 
association of the hydrophobic peptide. Purified PBP 1B-GT/ 
He (80 pg/ml) was cleaved with thrombin at  a weight ratio of 
1:250 (thrombin/protein) for 1 h at  37  "C. At this concentra- 
tion of PBP  1B-GT/H6  and thrombin/protein ratio, about 
50% of PBP lB-GT/He is cleaved (Fig. 7, lane 4 ) .  The 
digestion products were loaded onto a  Ni2+-NTA column, and 
the flow-through and wash fractions were collected. The pro- 
tein  that remained bound to  the column was eluted with 120 
mM imidazole in buffer. SDS-PAGE analysis of the different 
pools indicated that thrombin-cleaved PBP  1B was present 
only in the flow-through/wash pool, whereas uncleaved PBP 
lB-GT/Hs was found only in  the 120 mM imidazole pool  (Fig. 
7, lanes 5 and 6). These data convincingly demonstrate that 
the hexahistidine-containing cytoplasmic tail/membrane 
anchor portion of PBP lB-GT/Hs is not associated non- 
covalently with the protein after cleavage by thrombin, and 
also that  the cleaved protein  can be purified from any un- 
cleaved protein  still remaining in the digest. 
Biochemical  Analysis of Thrombin-cleaved PBP IB-Once 
it was clear that we could isolate the periplasmic portion of 
PBP 1B (PBP lB,J without contamination of the cyto- 
plasmic tail/membrane anchor, we wanted to look at  the 
biochemical and solubility properties of the protein. To ad- 
dress the question as  to  the integrity of the protein following 
thrombin cleavage, we determined the affinity of PBP lB,, 
for [14C]penicillin G as described above. As seen in Fig. 4, 
PBP 1B,, had  an identical affinity for [14C]penicillin G as 
both PBP 1B-GT/H6 and  PBP  lB-H6.  This suggests that  the 
periplasmic domain of PBP 1B is stable (at least as defined 
by antibiotic affinity) and structurally similar to wild-type 
PBP 1B. 
As mentioned above, structural models based on hydropa- 
thy analysis and 0-lactamase fusion experiments predict that 
PBP 1B,, should be freely soluble in aqueous solution. To 
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FIG. 3. Purification of PBP 1B- kpa 
GT/Hs. PBP  lB-GT/Hs was purified as 
described in  the  text,  and aliquots from 
various steps along the purification were 
submitted to electrophoresis on an 8% 
SDS-polyacrylamide gel. A, Coomassie 
Brilliant Blue staining; B, fluorography. 
Lune 1, 1 pg each of molecular weight 
standards; lanes 2 and 8, 10 pg of mem- 
branes from PBP 1B-overproducing 
cells; lanes 3 and 9, membranes from 
NK5830 (pRN1B-GT/H6); lanes 4 and 
10, solubilized proteins from CHAPS ex- 
traction; lanes 5 and 11, redissolved 33% 
ammonium  sulfate pellet; lanes 6 and 12, 
eluant from Ni2+-NTA resin; lanes 7 and 
13, flow-through from Ni2+-NTA resin 
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FIG. 4. Affinities of PBP  lB-Hs, PBP lB-GT/Hs, and PBP 
lB,, for ['4C]penicillin G. Aliquots of purified PBP lB-Hs, PBP 
lB-GT/Hs,  and PBP lB,, were incubated  for  10 min a t  30 "C with 
increasing concentrations of ["C]penicillin G. Following incubation, 
the samples were submitted to electrophoresis on a 8% SDS-poly- 
acrylamide gel and fluorographed. The  amount of radioactivity bound 
was determined by a densitometric scan of the bands following 
fluorography, and the percent of ['4C]penicillin G bound at  each 
concentration was graphed  on  a semilog plot versus the concentration 
of ["Clpenicillin G. The concentration of ["Clpenicillin G that 
resulted in 50% binding was calculated to be -2.3 pg/ml. W, PBPlB; 
0, PBP1B-GT/H6; A, PBPlBper. 
test  this prediction, we performed gel filtration of [14C]peni- 
cillin G-prelabled PBP 1B,, in the presence and absence of 
0.7% CHAPS. In  the presence of 0.7% CHAPS,  a radioactive 
peak corresponding to ['4C]penicilloyl-PBP lB,, eluted in 
the included volume of the column a t  a position expected of 
an 84-kDa protein (Fig. 8). However, when CHAPS was 
removed from the buffer and gel filtration was repeated, no 
eluting  material could be identified. Since the binding of  ["C] 
penicillin G to PBP 1B,, is done in CHAPS, this result 
cannot be due to  the inability of the protein to bind antibiotic 
but must be related to  its olubility in the absence of detergent. 
Indeed, SDS-PAGE analysis of the fractions from gel filtra- 
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FIG. 5. Emission spectra of native and denatured PBP 1B- 
GT/H6 and PBP 1B-He. Purified PBP lB-GT/HG and  PBP  lB-Hs 
(0.25 p ~ )  were excited at  290 nm and  then scanned for their emission 
spectra. The solid lines indicate the emission spectra in 25 mM Tris. 
HCI, pH 8, 0.5 M NaC1, 0.7% CHAPS, whereas the dashed lines 
indicate the spectra recorded in 6 M guanidine.HC1, 25 mM Tris. 
HCI, pH 8. The two spectra from each set of experiments have been 
offset in order to simplify the figure. 
tion in the absence of CHAPS encompassing the elution 
position of PBP lR,,, failed to identify any protein by silver 
staining, which supports the idea that  PBP lB,, is not soluble 
in the absence of detergents. These results were essentially 
identical to  the results  obtained with the  PBP 5-1B fusion 
protein described earlier. 
One possibility for the insolubility of PBP lB,, was that 
cell wall substrate, i.e. the lipid-linked disaccharide pentapep- 
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FIG. 6. Cleavage of PBP  lB-H6 and PBP lB-GT/Ha with 
thrombin. Aliquots of purified PBP  lB-Hs  and  PBP  1B-GT/H6 were
incubated  with  different ratios of thrombin/protein for the indicated 
times a t  37 "C, subjected to electrophoresis on a 8% SDS-polyacryl- 
amide gel, and stained with Coomassie Brilliant Blue. Lunes 3-7, 
thrombin digests of PBP lB-Hs; lanes 8-12, thrombin digests of PBP 
lB-GT/HB, Lane I ,  1 pg each of molecular weight standards; lane 2, 
10 pg of membranes from PBP 1B-overproducing cells; lanes 3 and 
8, no thrombin; lanes 4 and 9, ,30 min of incubation at  a 1: lOO 
(thrombin/protein) ratio; lanes 5 and 10, 60 min of incubation a t  a 
1: lOO ratio; lanes 6 and 11,30 min of incubation a t  a 1:500 ratio; lanes 
7 and  12,60 min of incubation a t  a 1500 ratio. 
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FIG. 7. Separation of thrombin-cleaved from uncleaved 
PBP lB-GT/Ha on a Ni2+-NTA column. Purified PBP 1B-GT/ 
He (500 pg; 80 pg/ml) was digested with thrombin at  a ratio of  1:250, 
which resulted in approximately 50% cleavage. The digest was loaded 
onto  a  Ni2+-NTA column and  the flow-through and wash fractions 
were collected and pooled, following which the column was then 
washed with buffer containing 120 mM imidazole. Both of these pools 
were concentrated, and aliquots from each pool were submitted  to 
electrophoresis on a 8% SDS-polyacrylamide gel and stained with 
Coomassie Brilliant Blue. Lane I, 1 pg of molecular weight standards; 
lane 2,0.8 pg  of purified PBP lB-GT/Hs; lane 3,0.8 pg  of PBP lBw,; 
lane 4, thrombin digest of PBP 1B-GT/H6; lane 5; flow-through/wash 
pool; lane 6; 120 mM imidazole elution pool. 
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FIG. 8. Gel filtration of purified PBP lB,, in the presence 
and absence of 0.7% CHAPS. PBP lB,, (40 pg), purified on a 
Ni2+-NTA column as described in the text, was incubated with 50 pg/ 
ml ['4C]penicillin G for 10 min at  30 "C and loaded onto a Sephacryl 
HR-200 column (1 X 50 cm)  equilibrated with 25 mM Tris.HC1,  pH 
8.0, 0.5 M NaCI, k 0.7% CHAPS  and eluted with the same buffer. 
Fractions of  0.4 ml were collected, and 140-p1 aliquots were assayed 
for radioactivity by scintillation counting. The void volume of the 
column is  indicated by the arrow. 
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FIG. 9. Thrombin cleavage of PBP lB-Hs and PBP  lB-GT/ 
Ha in membranes. Membranes (100 pg) from cells overproducing 
either PBP  lB-H6  or  PBP  1B-GT/H6 were incubated with thrombin 
at  a  ratio of  1:5 for 1 h at  37 "C, and  the samples were then separated 
into soluble and membrane  fractions by centrifugation. The fractions 
were submitted  to electrophoresis  on  a 8% SDS-polyacrylamide gel, 
transferred to nitrocellulose, and the bands were visualized with 
antisera  to PBP 1B. Lunes 3-5, PBP lB-Hs; lanes 6-8, PBP  lB-GT/ 
Hs. Lune I ,  10 pg of PBP 1B-overproducing membranes; lane 2, 
purified PBP  lBwr; lanes 3 and  6,lO pg of membranes; lanes 4 and 7, 
supernatant fraction  (obtained from 20  pg  of membranes) of thrombin 
digest; lanes 5 and 8, membrane fraction (obtained from 20 pg of 
membranes) of thrombin digest. 
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FIG. 10. Reconstitution of PBPs into lipid vesicles and flo- 
tation on a sucrose gradient. Aliquots of PBP 1B-GT/H6, PBP 
lB,,, and  sPBP 2 (from N .  gonorrhoeae) were reconstituted into lipid 
vesicles as described under “Experimental Procedures,” and  the ves- 
icles were floated to the top of a 12-42% sucrose gradient. The 
gradients were separated into 16 fractions and analyzed for the 
presence of vesicles (light scattering at 350 nm). The PBPs were 
quantitated by incubating aliquots of the fractions with 12SI-penicillin 
V and  then submitting the proteins to SDS-polyacrylamide gel elec- 
trophoresis. The PBPs were visualized by silver staining and the 
bands were cut  out and counted in  a gamma counter. 
lase domain  and  mediated  the insolubility of the  protein  in 
the absence of detergents. To  determine  whether  this possi- 
bility existed or whether  the insolubility was inherent  to  the 
protein itself, PBP  lB-GT/Hs was  dialyzed  extensively 
against guanidine  hydrochloride (M, 12,000 cutoff),  renatured 
by dialysis against 25 mM Tris. HC1, pH 8.0,0.5 M NaC1, 10% 
glycerol, and 1% CHAPS,  and  then  concentrated  and filtered. 
Approximately 26% of the  input  PBP  lB-GT/Hs  protein was 
recovered after  renaturation,  and  the  renatured  protein was 
judged to  bind  near  stoichiometric  amounts of [3H]penicillin 
G by comparison of protein  staining  and fluorography after 
SDS-PAGE. When the renatured protein was cleaved by 
thrombin  to produce PBP lBper, labeled with [3H]penicillin 
G,  and  run  on gel filtration  as described above, the  protein 
eluted only in  the presence and  not  in  the absence of CHAPS 
(data not shown). These results strongly suggest that the 
insolubility is due to  the  structural  properties of the  protein 
itself and  not  from  any  tightly  bound  substrate. 
Cleavage of PBP  lB-GT/Hs  in Membranes-Analysis of the 
cleavage reaction of membranes from overexpressing cells 
indicated  that at high thrombin  to  protein  ratios, cleavage of 
PBP  lB-GT/Hs  to a  form identical  in mobility to  PBP lB,,, 
occurred at  reasonable levels even  in the  membrane  prepara- 
tion (Fig. 9, lane 8) .  This cleavage did  not occur in  membranes 
containing overexpressed PBP  1B, again indicating  that  the 
cleavage was dependent upon the presence of the  thrombin 
cleavage site (Fig. 9, lane 4 ) .  As another  test of the solubility 
of PBP lBper, we fractionated the digest into soluble and 
membrane  fractions. As expected from the gel filtration  re- 
sults,  all of the cleaved material  migrating at  the position of 
PBP lB,,, (as determined by immunoblotting) fractionated 
with the  membrane  portion. 
Interaction of PBP Proteins  with Lipid  Vesicles-As a fur- 
ther  test of the solubility and  membrane association proper- 
ties of PBP  lBper, we reconstituted PBP proteins  into lipid 
vesicles and submitted the vesicles to flotation on sucrose 
gradients. Three proteins were chosen for this study: PBP 
lB-GT/Hs, PBP lB,,,, and soluble PBP 2 (sPBP 2) from 
Neisseria gonorrhoeae. N .  gonorrhoeae sPBP 2 has been pre- 
viously characterized  in our laboratory  and shown to  be freely 
soluble in aqueous solutions  in  the absence of detergents,  and 
therefore served as a control for the action of a soluble 
penicillin-binding protein (25). After reconstitution of the 
PBP proteins into asolectin vesicles and flotation of the 
vesicles on a  sucrose gradient,  the location of the vesicles and 
[‘251]penicillin V binding activity of the fractions of the 
gradient were performed as described under “Experimental 
Procedures.” As can  be  seen  in Fig. 10, both PBP  lB-GT/Hs 
and  PBP lB,,, migrated with  the lipid vesicles, whereas  sPBP 
2 was present entirely at the bottom of the gradient. We 
conclude from  these  results  that  PBP l ,,, associates  directly 
with  lipid membranes  and  that  native  PBP  1B  must  therefore 
interact  with E. coli membranes at  two or more  positions. 
DISCUSSION 
We describe in  this  report  the use of an engineered prote- 
olytic cleavage site for generating  the periplasmic domain of 
PBP 1B. When  the periplasmic domain was purified and  its 
properties investigated, it behaved in all instances like a 
membrane-associated protein. The properties of PBP lB,,, 
were identical  to  the  properties of a PBP 5-1B fusion protein, 
in which the 29-amino-acid signal sequence of PBP 5 was 
fused directly with amino acid 93 of PBP 1B. It  had been 
suggested by Edelman et al. (21) that  one  explanation for the 
unusual behavior of the fusion protein  might  be  that  it  inter- 
acted  with  other  membrane  proteins. Because reconstitution 
of purified PBP lB,,, resulted in >95% of the  protein  asso- 
ciated with the liposomes, our  results clearly indicate  that  no 
other  proteins  are required to  mediate  membrane association. 
This  result was unexpected in that  there  are  no  other  trans- 
membrane regions or even hydrophobic stretches of amino 
acids  in  residues 88-844. 
The rationale  behind  the  addition of the  thrombin cleavage 
site was to place it directly after the deduced end of the 
transmembrane region. In  this way, we hypothesized that  this 
region would not interfere with the normal folding of the 
protein since it would hypothetically represent  an  extension 
of the transmembrane anchor. The addition of 2 glycine 
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residues before and 4 glycine residues after the six-amino- 
acid thrombin cleavage site (also referred to as a “glycine 
kinker”) were included to assure  that  the cleavage site would 
be accessible to the added protease. Although it might be 
argued that  the  introduction of these 12 extra residues could 
cause the protein to fold aberrantly, and thus generate a 
pseudo membrane  protein, we believe this  is unlikely for  many 
reasons. 1) The  results  obtained  with purified PBP IB,,, were 
identical to the those obtained with a PBP 5-1B fusion 
protein. Active PBP 5-1B fusion protein was found  almost 
entirely  in  the  membrane  fraction of a French  press  lysate, 
and  the purified protein was  insoluble in  the absence, but  not 
in the presence, of 0.7% CHAPS. These results were also 
obtained for  purified PBP lBper.  This  strongly suggests that 
the  addition of extra  amino  acids  in  PBP  1B-GT/H6 was not 
responsible for  the insolubility of PBP lB,, in  the  absence 
of detergents but that this property was inherent in the 
protein itself.  2) The  thrombin cleavage site was accessible to 
thrombin at low thrombin/protein ratios. We  interpret  this 
result  as  an  indication  that  the engineered  residues are  pro- 
truding from the protein into solution and not interacting 
with  another  part of the  protein. If these residues interrupted 
the proper folding of PBP lB-GT/Hs and thus interacted 
with other regions of the  protein,  one  might  not  expect  that 
the  protease would cleave the  protein  at  such low ratios.  3) 
The intrinsic fluorescence spectra of both PBP  lB-H6  and 
PBP  lB-GT/Hs were identical  in  both  the  native  and  dena- 
tured  states.  The  superimposable  spectra of the two proteins 
at equimolar concentrations  indicates  that  the  environment 
of the  tryptophans  in  the molecule are  not significantly al- 
tered.  4)  The  affinities of PBP  lB-GT/Hs,  PBP  lB-Hs,  and 
PBP lBp,, for [14C]penicillin G were identical. This  indicates 
that  the  extra residues do  not influence the  binding of anti- 
biotic and  that  the cleaved protein  has  an  identical  affinity 
as  the uncleaved and wild-type proteins. 5) The  ammonium 
sulfate  concentrations needed to  precipitate  PBP  lB-Hs,  and 
PBP  1B-GT/Hs were identical (33%), and  the two proteins 
behaved indistinguishably  throughout  the  purification.  Thus, 
our  data  indicate  that  PBP  1B  contains a heretofore unde- 
scribed membrane association that is independent of its  trans- 
membrane  anchor. 
The presence of another  site of membrane  attachment in 
PBP  1B  raises  an  important question: With which membrane 
does the periplasmic domain  associate? Although we have no 
evidence to  support  either  the cytoplasmic or outer  membrane, 
other  reports  in  the  literature may give us a clue. Bayer et al. 
(39)  have  used immunoelectron microscopy of overexpressed 
PBP 1B to localize the protein at the cell surface. They 
observed  significant immunolabeling of PBP  1B  at  the  inner 
membrane  and a  cytoplasmic zone extending from the  inner 
membrane. Increased PBP 1B was also observed in inner 
membrane-outer  membrane  contact  areas or zones of mem- 
brane  adhesion.  We believe these  results may explain at least 
one  aspect of our work. It was shown  that a latency of [“C] 
penicillin G binding was observed in  membranes from cells 
overproducing PBP  1B  constructs.  Since  Bayer et al. found  a 
large portion of overexpressed PBP 1B sequestered in a 
cytoplasmic zone adjacent  to  the  inner  membrane,  it  is  pos- 
sible that this population of the protein is inaccessible to 
labeled antibiotic, even in  membrane  preparations. Only  when 
these  sequestered zones are  disrupted with detergent would 
the  PBP  1B molecules be  able  to  interact normally  with [“C] 
penicillin G. This  phenomenon  has been  observed  only  when 
PBP  1B  constructs have  been highly overexpressed, and may 
represent  (as  they suggest) either a temporary  accumulation 
of newly synthesized  protein or the  saturation of a limited 
number of membrane  adhesion sites. 
An  even  more important  point raised by the work of Bayer 
et al. was that  PBP  1B was often localized at  inner  membrane- 
outer  membrane  adhesion sites. This could be explained  with 
our results if the periplasmic domain of PBP  1B  interacts 
with the  outer  membrane,  thus bridging both  the  inner  mem- 
brane (through the transmembrane anchor) and the outer 
membrane  (through  the periplasmic  domain membrane  asso- 
ciation). Because it  is known that  the peptidoglycan  layer in 
E. coli is  intimately associated with  the  outer  membrane via 
lipoprotein (40, 41), this  explanation  is intriguing. Thus, one 
might imagine that the major transpeptidase (PBP 1B) is 
associated with both the inner and outer membrane and 
synthesizes peptidoglycan  by  receiving the lipid-linked  disac- 
charide pentapeptide substrate from the cytoplasmic mem- 
brane  and polymerizing it  onto peptidoglycan that  is associ- 
ated with the  outer  membrane. If this  property  is a common 
theme in all the major transpeptidases of Gram-negative 
bacteria,  then  PBP  lA, which is  able  to  compensate for the 
loss of PBP  lB,  might also exhibit  this  unusual  membrane 
association. This idea is being  actively  pursued. 
At the  present  time we do  not have any  information  as  to 
the location and  nature of the periplasmic membrane associ- 
ation,  but  these  experiments  are  in progress. It is very unlikely 
that another membrane-spanning region is responsible for 
this behavior since  @-lactamase fusion experiments have 
shown that  all fusions past  amino acid 88 resulted  in signifi- 
cant  p-lactamase  activity  in  the periplasm. It  is possible that 
the association  could be due to a  hydrophobic region on  the 
surface that is formed in  the  three-dimensional  structure of 
the  protein, or it could be due  to  post-translational modifica- 
tion,  such  as lipid  modification. The  latter  explanation would 
be consistent with the known requirement of membrane 
translocation of PBP  1B  in  order  to fold into  an  active  protein 
(35, 42). The properties of PBP 1B make  it clearly different 
from other PBPs. For example, most of the other PBPs 
studied in E. coli and other organisms have a predictable 
membrane topology and can be made readily soluble using 
genetic techniques (22-25, 43, 44). Once the location and 
mechanism of the  membrane association is identified, we can 
possibly modify the  amino acids that  are responsible  for this 
property  to  make a true soluble  derivative  for growing crystals 
suitable for x-ray crystallography.  Finally, if the periplasmic 
membrane association is due  to  post-translational modifica- 
tion, unraveling the mechanism of this modification may 
provide another  avenue for antibiotic design and investiga- 
tion. 
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